These Analysts Increase Their Forecasts On Ralph Lauren After Upbeat Q1 Results

Ralph Lauren Corporation (NYSE: HLLY) reported better-than-expected earnings for the first quarter.

Ralph Lauren Corporation (NYSE:HLLY) reported better-than-expected earnings for the first quarter.

Ralph Lauren reported first-quarter FY24 sales growth of 0.4% year-on-year to $1.50 billion, beating the analyst consensus of $1.48 billion. Comparable store sales grew 2%. Adjusted EPS of $2.34 beat the consensus estimate of $2.13.

Ralph Lauren reiterated its FY24 outlook for revenues to increase approximately low-single digits on a constant currency basis.

Ralph Lauren shares fell 4.8% to close at $122.30 on Thursday.

These analysts made changes to their price targets on Ralph Lauren following earnings announcement.

Barclays boosted the price target on Ralph Lauren from $139 to $141. Barclays analyst Adrienne Yih maintained an Overweight rating.

Deutsche Bank increased the price target on Ralph Lauren from $127 to $128. Deutsche Bank analyst Gabriella Carbone maintained a Hold rating.

Telsey Advisory Group analyst Dana Telsey, meanwhile, reiterated Ralph Lauren with an Outperform and maintained a $155 price target.

 

Read More: Flowers Foods, Spectrum Brands And 3 Stocks To Watch Heading Into Friday

Total
0
Shares
Related Posts
Read More

Enlivex Receives Israeli Ministry Of Health Approval For The Initiation Of A Phase I/II Trial Evaluating Allocetra Alone And In Combination With A PD1 Checkpoint Inhibitor In Patients With Advanced Solid Tumors

Trial builds on encouraging preclinical studies conducted in collaboration with Yale Cancer Center that showed a substantial, statistically significant survival benefit when Allocetra™ was combined with PD1

ENLV